News headlines about Nutrisystem (NASDAQ:NTRI) have been trending somewhat positive this week, according to Accern Sentiment Analysis. The research group identifies positive and negative media coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Nutrisystem earned a daily sentiment score of 0.18 on Accern’s scale. Accern also gave news stories about the company an impact score of 45.5377884246375 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.
Here are some of the media headlines that may have impacted Accern’s analysis:
- Just the Facts on: The Goodyear Tire & Rubber Company, (NASDAQ: GT), Nutrisystem, Inc., (NASDAQ: NTRI) (globalexportlines.com)
- Trader’s Buzzers: BioAmber Inc. (NYSE:BIOA), Nutrisystem, Inc. (NASDAQ:NTRI) (oracleexaminer.com)
- EY Announces Dawn Zier, CEO of Nutrisystem, Inc., Entrepreneur Of The Year® 2018 Award Finalist in Greater … (businesswire.com)
- Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), Nutrisystem, Inc. (NASDAQ: NTRI) – Choosing Between: (productioninvestments.com)
- What Are Analysts Saying? Nutrisystem, Inc. (NTRI) (mostvolatilestocks.com)
Shares of NASDAQ NTRI opened at $29.50 on Tuesday. Nutrisystem has a 1-year low of $26.06 and a 1-year high of $67.95. The stock has a market cap of $850.36, a PE ratio of 15.05, a P/E/G ratio of 0.83 and a beta of 1.12.
NTRI has been the topic of several recent analyst reports. Barrington Research lowered shares of Nutrisystem from an “outperform” rating to a “market perform” rating in a report on Tuesday, February 27th. BidaskClub lowered shares of Nutrisystem from a “sell” rating to a “strong sell” rating in a report on Thursday, April 19th. B. Riley set a $52.00 price objective on shares of Nutrisystem and gave the company a “buy” rating in a report on Wednesday, February 28th. Craig Hallum dropped their price objective on shares of Nutrisystem from $80.00 to $50.00 and set a “buy” rating on the stock in a report on Tuesday, February 27th. Finally, Lake Street Capital reiterated a “buy” rating and set a $48.00 price objective (down previously from $73.00) on shares of Nutrisystem in a report on Tuesday, February 27th. Two research analysts have rated the stock with a sell rating, four have assigned a hold rating and six have given a buy rating to the company. The company has a consensus rating of “Hold” and an average target price of $57.00.
In other news, insider Dawn M. Zier sold 30,825 shares of the business’s stock in a transaction dated Monday, February 12th. The shares were sold at an average price of $40.37, for a total transaction of $1,244,405.25. Following the completion of the sale, the insider now directly owns 221,013 shares of the company’s stock, valued at $8,922,294.81. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Insiders own 2.04% of the company’s stock.
Nutrisystem Company Profile
Nutrisystem, Inc, together with its subsidiaries, provides weight management products and services for women and men in the United States. The company offers weight loss programs that consist primarily of a pre-packaged food program, digital tools, and counseling. It also provides Nutrisystem Lean13 program, which provides weight loss, and support and counseling services; the South Beach Diet, a weight-loss program; and Nutrisystem 5-day kit, a ?D' kit that offers individuals with or at risk of type 2 diabetes.
Receive News & Ratings for Nutrisystem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrisystem and related companies with MarketBeat.com's FREE daily email newsletter.